JPMorgan International Value ETF
JIVE · ETF
About JIVE
- Issuer
- JPMorgan
- Expense ratio
- 0.55%
- Assets under management
- $4.45B
- Inception
- Sep 13, 2023
- Asset class
- Equity
- Website
- am.jpmorgan.com
JIVE key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 482.97K
- Volume
- 334.70K
- Open price
- $94.00
- High today
- $94.75
- Low today
- $93.80
- 52 Week high
- $100.21
- 52 Week low
- $75.19
JPMorgan International Value ETF (JIVE) at a glance
As of Oct 20, 2026, JPMorgan International Value ETF (JIVE) shares are priced at $94.50, giving the company a price-to-earnings ratio of 0.00.
Today the fund has traded between $93.80 and $94.75. The current price is 0.7% above the day's low and 0.3% below its high.
Volume so far is 334.70K shares, below the average of 482.97K shares a day.
Over the past year JPMorgan International Value ETF has ranged from $75.19 to $100.21, and now sits 77% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.